Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2021-04-22 Regulatory Filings
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
Biocartis kondigt samenwerking met SkylineDx aan
Regulatory Filings Classification · 95% confidence The document is titled "PERSBERICHT GEREGLEMENTEERDE INFORMATIE" (Press Release Regulated Information) and announces a partnership agreement between Biocartis and SkylineDx regarding the development of the Merlin Assay on the Idylla platform. It details a business development, financial investment (convertible bonds), and future plans. This type of announcement, which communicates significant business events, strategic partnerships, or material non-public information outside of routine financial reporting (like 10-K or ER), is typically classified as a general regulatory announcement or press release. Since it is not a formal financial report (10-K, IR, ER, MRQ) nor a specific corporate action like a dividend (DIV) or share transaction (POS), and it is a formal announcement of regulated information, the most appropriate category is Regulatory Filings (RNS), which serves as a broad category for such official disclosures that don't fit elsewhere. The length (12,927 chars) suggests it is the full content, not just a brief RPA.
2021-04-22 Dutch
AGM EGM 2021 - Attendance Form (DUT ENG) (final).pdf
Proxy Solicitation & Information Statement Classification · 99% confidence The document is titled 'DEELNEMINGSFORMULIER VOOR HOUDERS VAN EFFECTEN' (ATTENDANCE FORM FOR SECURITIES HOLDERS) and explicitly refers to 'Gewone en buitengewone algemene aandeelhoudersvergaderingen' (Annual and extraordinary shareholders' meetings) scheduled for May 14, 2021. This form is used by shareholders to register their intent to attend the meeting, either in person or via videoconference, and is a preparatory document for the meeting itself. This strongly indicates materials related to the Annual General Meeting (AGM). Since it is the form for attendance/participation rather than the final voting results (DVA) or the proxy solicitation materials (PSI), the most appropriate classification is AGM-R, which covers presentations and materials shared during the AGM, often including the necessary administrative forms.
2021-04-13 Dutch
AGM EGM 2021 - Board Report 7199 BCCA (DUT) (final)_SIGNED.pdf
Capital/Financing Update Classification · 98% confidence The document is titled "BIJZONDER VERSLAG VAN DE RAAD VAN BESTUUR OVEREENKOMSTIG ARTIKEL 7:199 VAN HET WETBOEK VAN VENNOOTSCHAPPEN EN VERENIGINGEN" (Special Report of the Board of Directors pursuant to Article 7:199 of the Companies and Associations Code). It explicitly discusses a proposal to renew the authorization for the Board of Directors to increase the company's capital within the limits of the authorized capital ('toegestane kapitaal'). This type of document, which details a proposal for capital structure changes and seeks shareholder approval (to be presented at an EGM), falls under the category of Capital/Financing Update (CAP). Although it is a formal report, its core subject is the authorization for capital changes, making CAP more specific than a general regulatory filing (RNS) or a general governance report (CGR). It is not a full Annual Report (10-K) or an Interim Report (IR).
2021-04-13 Dutch
Biocartis Group NV_Statutory Annual Accounts (DUT)_SIGNED.pdf
Audit Report / Information Classification · 98% confidence The document text is in Dutch and contains the heading "JAARREKENING EN ANDERE OVEREENKOMSTIG HET WETBOEK VAN VENNOOTSCHAPPEN EN VERENIGINGEN NEER TE LEGGEN DOCUMENTEN" (Annual Accounts and other documents to be filed pursuant to the Code of Companies and Associations). It explicitly lists the financial period covered: "boekjaar dat de periode dekt van 01-01-2020 tot 31-12-2020" (financial year covering the period from 01-01-2020 to 31-12-2020). Furthermore, it includes a detailed "BALANS NA WINSTVERDELING" (Balance Sheet after appropriation of profits) with standard accounting line items. This structure and content strongly indicate a full annual financial report, which corresponds to the Annual Report (10-K) category, even though the document is in Dutch and likely filed with a local regulator (like Belgium's Crossroads Bank for Enterprises, given the RPR/Ondernemingsrechtbank references). Since the content is the full financial statement itself, it is not an RPA or ER. FY 2020
2021-04-13 Dutch
AGM EGM 2021 - Vote by mail (DUT ENG) (final).pdf
AGM Information Classification · 99% confidence The document is explicitly titled 'FORMULIER VOOR STEMMING PER BRIEF' (Vote By Mail Form) for the 'Gewone en buitengewone algemene aandeelhoudersvergaderingen' (Annual and extraordinary shareholders' meetings) scheduled for May 14, 2021. This form is used by shareholders to cast their votes on the agenda items prior to the meeting. The agenda items cover standard AGM topics like approval of financial statements, discharge of directors/auditors, and remuneration policy. A document specifically designed for shareholders to submit their votes for an upcoming general meeting falls under the category of materials related to the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2021-04-13 Dutch
AGM EGM 2021 - Proxy (DUT ENG) (final).pdf
AGM Information Classification · 98% confidence The document is titled "VOLMACHT PROXY" and explicitly refers to the "Gewone en buitengewone algemene aandeelhoudersvergaderingen" (Annual and extraordinary shareholders' meetings) scheduled for May 14, 2021. It is a form used by shareholders to appoint a proxy holder to vote on their behalf at these meetings. The agenda items discuss the approval of financial statements (for the year ended Dec 31, 2020) and granting discharge to directors and the auditor, which are typical items for an Annual General Meeting (AGM). Since this document is the proxy form used to facilitate voting at the AGM, it falls under the category of materials related to the Annual General Meeting. It is not the AGM presentation itself (AGM-R), nor is it the full Annual Report (10-K). It is a document soliciting votes/representation for the meeting, which aligns best with the scope of AGM-related materials, specifically the proxy solicitation aspect, which is closely related to DEF 14A (Proxy Statement) or AGM-R. Given the options, AGM-R (AGM Information) is the most appropriate fit for materials directly related to the mechanics and execution of the Annual General Meeting.
2021-04-13 Dutch

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.